Evidence map›Paper›PMID 36621559›Full record

ArticleEnvironmental toxicology and pharmacology2023

Effect of lifestyle-based lipid lowering interventions on the relationship between circulating levels of per-and polyfluoroalkyl substances and serum cholesterol.

Stephanie Morgan, M Abdul Mottaleb, Maria P Kraemer, Debra K Moser, Jessica Worley, Andrew J Morris, Michael C Petriello

Abstract read
In one paragraph

Article in Environmental toxicology and pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Stephanie MorganInstitute of Environmental Health Sciences, Wayne State University, Detroit, MI 48202, USA.
M Abdul MottalebDivision of Cardiovascular Medicine, College of Medicine, University of Kentucky, Lexington, KY 40536, USA; Lexington Veterans Affairs Medical Center, Lexington, KY, USA.
Maria P KraemerLexington Veterans Affairs Medical Center, Lexington, KY, USA.
Debra K MoserCollege of Nursing, University of Kentucky, Lexington, KY 40536, USA.
Jessica WorleyInstitute of Environmental Health Sciences, Wayne State University, Detroit, MI 48202, USA.
Andrew J MorrisDivision of Cardiovascular Medicine, College of Medicine, University of Kentucky, Lexington, KY 40536, USA; Lexington Veterans Affairs Medical Center, Lexington, KY, USA.
Michael C PetrielloInstitute of Environmental Health Sciences, Wayne State University, Detroit, MI 48202, USA; Lexington Veterans Affairs Medical Center, Lexington, KY, USA; Department of Pharmacology, School of Medicine, Wayne State University, Detroit, MI 48202, USA. Electronic address: Michael.petriello@wayne.edu.

Funding

Pilot Project ProgramP30ES026529 · NIEHS · UNIVERSITY OF KENTUCKY · PI John Anthony Bauer · 2017 to 2026
$15.4M
Research Experience & Training Coordination CoreP42ES030991 · NIEHS · WAYNE STATE UNIVERSITY · PI Yongli Wager · 2022 to 2026
$13.9M
Pilot Project ProgramP30ES020957 · NIEHS · WAYNE STATE UNIVERSITY · PI RUNGE-MORRIS, MELISSA A · 2014 to 2021
$10.1M
TMAO is a biomarker of dioxin-like pollutant exposure and cardiometabolic diseaseR00ES028734 · NIEHS · WAYNE STATE UNIVERSITY · PI PETRIELLO, MICHAEL CURTIS · 2019 to 2021
$747k
Lysophosphatidic Acid and Cardiovascular Disease RiskI01BX005637 · VA · VA MEDICAL CENTER - LEXINGTON, KY · PI MORRIS, ANDREW J, SMYTH, SUSAN S. · 2021 to 2024
–
Acquisition of an HPLC Electrospray/chemical ionization triple quadrupole linear ion trap mass spectrometer system.IS1BX003153 · VA · VA MEDICAL CENTER - LEXINGTON, KY · PI MORRIS, ANDREW J · 2015 to 2015
–
BLRD VA I01 BX005637BLRD VA IS1 BX003153NIEHS NIH HHS P30 ES020957NIEHS NIH HHS P30 ES026529NIEHS NIH HHS P42 ES030991NIEHS NIH HHS R00 ES028734
6 · The paper itself

Abstract

Exposure to certain per-and polyfluoroalkyl substances (PFAS) has been shown to be positively associated with total and/or low-density lipoprotein cholesterol. Examining this association in lipid lowering interventions may provide additional evidence linking PFAS to cardiovascular risk. We examined the relationship of 6 PFAS with cholesterol in a 6-month lifestyle-based intervention. We quantitated PFAS in 350 individuals at baseline and post intervention and examined associations of PFAS with cholesterol before and after intervention. Food frequency questionnaires and GIS analyses were used to investigate PFAS hotspots and possible exposure routes. Cholesterol significantly decreased following intervention and in parallel, PFOS, PFOA, PFHxS, and PFHpA significantly decreased. PFOS was positively correlated with total cholesterol only post-intervention. We observed that PFOS was distributed among both non-albumin and albumin lipoprotein fractions pre-intervention, but entirely in albumin fraction post-intervention. Our results indicate that lipid-lowering via lifestyle modification may impact on circulating levels or distribution of PFAS.

Indexed as

Alkanesulfonic AcidsEnvironmental PollutantsFluorocarbonsCholesterolCholesterol, LDLHumansLife StyleAlkanesulfonic AcidsCholesterolCholesterol, LDLEnvironmental PollutantsFluorocarbonsAtherosclerosisCardiovascular diseaseCholesterolPFASPFOS

Identifiers

PMID36621559
PMCPMC9992109

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.